Neuronetics, Inc. (STIM) Income Statement
STIM 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsSTIM revenue and net income
Where STIM's revenue goes
2025Each bar shows an amount and its share of revenue. STIM kept −26.1% of revenue as net income.
STIM profit margins
STIM growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +99.2% | +31.8% | +24.8% | — |
| Gross profit | +33.5% | +13.3% | +13.9% | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
STIM quarterly EPS vs estimates
Neuronetics beat the analyst EPS estimate in 3 of the last 8 quarters. Next report: November 3, 2026 (estimate $-0.08).
STIM income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $149.2M | $74.9M | $71.3M | $65.2M | $55.3M | $49.2M | $62.7M | $52.8M | $40.4M | $34.2M |
| Cost of revenue | $76.8M | $20.7M | $19.6M | $15.5M | $11.7M | $11.6M | $15.4M | $12.4M | $9.6M | $6.6M |
| Gross profit | $72.3M | $54.2M | $51.7M | $49.7M | $43.7M | $37.7M | $47.3M | $40.3M | $30.8M | $27.6M |
| Research & development | $6.6M | $12.8M | $9.5M | $9.3M | $7.9M | $9.2M | $13.7M | $8.2M | $7.9M | $8.2M |
| Sales, general & admin | $97.2M | $76.0M | $72.7M | $75.5M | $63.3M | $50.8M | $60.5M | $51.9M | $36.5M | $28.7M |
| Total operating expenses | $103.7M | $88.7M | $82.3M | $84.8M | $71.2M | $60.0M | $74.2M | $60.2M | $44.4M | $36.9M |
| Operating income | −$31.4M | −$34.6M | −$30.6M | −$35.1M | −$27.6M | −$22.3M | −$26.9M | −$19.8M | −$13.6M | −$9.3M |
| Interest income | — | — | — | — | — | — | $3.7M | $3.7M | $2.8M | $1.8M |
| Interest expense | $8.4M | $7.3M | $5.4M | $3.6M | $3.3M | $4.5M | $3.7M | $3.7M | $2.8M | $1.8M |
| Income before taxes | −$39.0M | −$43.7M | −$30.2M | −$37.2M | −$31.2M | −$27.5M | −$29.0M | −$24.1M | −$16.1M | −$11.2M |
| Income taxes | — | −$14,000 | −$24,000 | $2.0M | $4.4M | $4.8M | $5.3M | −$575,000 | $3.2M | $1.8M |
| Net income | −$39.0M | −$43.7M | −$30.2M | −$37.2M | −$31.2M | −$27.5M | −$29.0M | −$24.1M | −$16.1M | −$11.2M |
| EBITDA | −$27.1M | −$34.4M | −$22.8M | −$32.0M | −$26.8M | −$25.9M | −$27.2M | −$19.5M | −$12.7M | −$8.7M |
| EPS (diluted) | −$0.59 | −$1.37 | −$1.07 | −$1.38 | −$1.20 | −$1.41 | −$1.59 | −$1.29 | −$1433.84 | — |
| Gross margin | 48.5% | 72.3% | 72.5% | 76.3% | 78.9% | 76.5% | 75.4% | 76.4% | 76.2% | 80.7% |
| Operating margin | −21.1% | −46.2% | −42.8% | −53.8% | −49.8% | −45.3% | −43.0% | −37.6% | −33.7% | −27.3% |
| Net margin | −26.1% | −58.4% | −42.3% | −57.0% | −56.4% | −55.7% | −46.4% | −45.7% | −39.7% | −32.8% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.6M | $34.5M | $41.8M | $37.3M | $38.1M | $32.0M | $22.5M | $18.5M | $16.4M | $17.4M | $20.3M | $17.9M |
| Cost of revenue | $20.3M | $18.3M | $20.1M | $20.2M | $20.4M | $16.2M | $7.6M | $4.5M | $4.3M | $4.3M | $4.5M | $6.1M |
| Gross profit | $21.2M | $16.2M | $21.7M | $17.1M | $17.8M | $15.7M | $14.9M | $14.0M | $12.2M | $13.1M | $15.8M | $11.8M |
| Research & development | $1.3M | $1.4M | $1.7M | $1.5M | $1.8M | $1.6M | $5.8M | $2.4M | $2.2M | $2.3M | $2.2M | $2.2M |
| Sales, general & admin | $21.4M | $23.8M | $25.1M | $22.9M | $24.0M | $25.1M | $20.6M | $19.3M | $18.5M | $17.6M | $18.0M | $18.5M |
| Total operating expenses | $22.7M | $25.1M | $26.7M | $24.4M | $25.8M | $26.8M | $26.4M | $21.7M | $20.7M | $19.9M | $20.2M | $20.6M |
| Operating income | −$1.5M | −$9.0M | −$5.0M | −$7.3M | −$8.1M | −$11.0M | −$11.5M | −$7.7M | −$8.5M | −$6.9M | −$4.4M | −$8.9M |
| Interest expense | $2.1M | $2.3M | $2.1M | $2.1M | $2.0M | $1.9M | $1.6M | $1.7M | $2.0M | $1.8M | $1.8M | $1.2M |
| Income before taxes | −$3.4M | −$10.8M | −$7.2M | −$9.4M | −$9.9M | −$12.7M | −$12.7M | −$13.3M | −$9.8M | −$7.9M | −$5.4M | −$9.4M |
| Income taxes | — | — | — | — | — | — | — | — | — | $516,724 | −$7.2M | $1.8M |
| Net income | −$3.4M | −$10.8M | −$7.2M | −$9.0M | −$10.1M | −$12.7M | −$12.7M | −$13.3M | −$9.8M | −$7.9M | −$5.4M | −$9.4M |
| EBITDA | −$1.2M | −$7.8M | −$4.3M | −$6.4M | −$7.2M | −$9.9M | −$10.7M | −$11.1M | −$7.3M | −$5.5M | −$3.6M | −$7.7M |
| EPS (diluted) | −$0.05 | −$0.15 | −$0.10 | −$0.13 | −$0.15 | −$0.21 | −$0.33 | −$0.44 | −$0.33 | −$0.27 | −$0.19 | −$0.33 |
| Gross margin | 51.1% | 46.9% | 52.0% | 45.9% | 46.6% | 49.2% | 66.2% | 75.6% | 74.0% | 75.1% | 77.6% | 65.8% |
| Operating margin | −3.6% | −26.1% | −12.1% | −19.6% | −21.1% | −34.4% | −51.0% | −41.7% | −51.7% | −39.4% | −21.8% | −49.6% |
| Net margin | −8.3% | −31.3% | −17.1% | −24.3% | −26.6% | −39.6% | −56.3% | −72.0% | −59.8% | −45.2% | −26.5% | −52.5% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in STIM's financial statements (latest annual report filed March 17, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
STIM financial results
In fiscal year 2025 (ended December 31, 2025), Neuronetics reported revenue of $149.2 million, up 99.2% from the year before. It had a net loss of $39.0 million, a net profit margin of −26.1%. Diluted earnings per share came to −$0.59. Over five years revenue grew at an average rate of 24.8% a year.
See the STIM stock overview for the latest quote and news, or the STIM chart for price history and technical indicators.
STIM income statement FAQ
What is Neuronetics's annual revenue?
Neuronetics reported total revenue of $149.2 million for fiscal year 2025, which ended on December 31, 2025. That was up 99.2% from $74.9 million the previous year.
Is Neuronetics profitable?
No. Neuronetics reported a net loss of $39.0 million in fiscal 2025, a net profit margin of −26.1%; its operating margin was −21.1%.
What is Neuronetics's gross margin?
Neuronetics's gross margin was 48.5% in fiscal 2025: for every $100 of revenue, Neuronetics kept $48 after the direct cost of its products and services.
How much does Neuronetics spend on research and development?
Neuronetics spent $6.6 million on research and development in fiscal 2025, 4.4% of revenue.
How fast is Neuronetics growing?
Revenue grew 24.8% a year on average over the last five fiscal years, from $49.2 million to $149.2 million.
What are Neuronetics's earnings per share?
Neuronetics earned $-0.59 per diluted share in fiscal 2025, compared with $-1.37 a year earlier.
When will Neuronetics report its next earnings?
Neuronetics is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 before the market opens.
When does Neuronetics's fiscal year end?
Neuronetics's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 17, 2026.